Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART-ROAD: Rosuvastatin and Olmesartan in Coronary Atherosclerosis
NCT02516826Phase 2Unknown
- Sponsor
- Samsung Medical Center
- Start
- Aug 2015
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olmesartan in coronary artery disease (CAD), sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
olmesartan
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02516826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02516826.